---
title: "Biodexa Pharmaceuticals (BDRX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/BDRX.US/norm.md"
symbol: "BDRX.US"
name: "Biodexa Pharmaceuticals"
parent: "https://longbridge.com/zh-HK/quote/BDRX.US.md"
datetime: "2026-03-05T04:01:52.268Z"
locales:
  - [en](https://longbridge.com/en/quote/BDRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BDRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BDRX.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/BDRX.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/BDRX.US/norm.md)


# Biodexa Pharmaceuticals (BDRX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -10.32 | -9.75 | -22.92 | -24.44 | -63.73 |
| ROE | -66.56% | -77.05% | -58.18% | -56.80% | -75.81% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -2.61M | -2.46M | -1.52M | -1.62M | -2.09M |
| 營業利潤 | -2.75M | -2.60M | -3.12M | -3.33M | -2.67M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 20.32M | 19.19M | 18.54M | 19.77M | 17.66M |
| 權益乘數 | 1.30 | 1.30 | 1.78 | 1.78 | 1.60 |
| 每股凈資產 | 25.30 | 23.90 | 156.16 | 166.50 | 304.24 |
| 資產周轉率 | - | - | - | 0.0033 | 0.0076 |
| 現金及短投 | 5.53M | 5.22M | 2.09M | 2.23M | 6.39M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 256318.88 | 242074.33 | 406488.77 | 433398.43 | 551152.24 |
| 凈債務 | -4.85M | -4.58M | -1.18M | -1.26M | -5.91M |

## 現金流量表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -2.26M | -2.14M | -4.68M | -4.99M | -3.04M |
| 投資現金流 | -232331.82 | -219420.32 | 97858.41 | 104336.66 | -476569.71 |
| 融資現金流 | 4.12M | 3.89M | 2.45M | 2.62M | 2.94M |
| 自由現金流 | -1.81M | -2.05M | -1.74M | -6.61M | -2.03M |
| 現金流充裕率 | -1418.03% | -1418.03% | -7307.84% | -7307.84% | -5168.82% |
| 舉債與償債 | - | - | 270365.21 | 288263.46 | - |
| 資本支出 | -1370.69 | -1294.52 | -5645.68 | -6019.42 | - |